TREATMENT OF AUTOIMMUNE HEMOLYTIC ANAEMIA WITH RITUXIMAB

<p>Background. Autoimmune haemolytic anaemia (AIHA) is characterised by the presence of autoantibodies directed against autologous erythrocytes. Depending on temperature at which they are active AIHA is classified as AIHA due to warm or cold-reacting antibodies. Glucocorticoids are the mainsta...

Full description

Bibliographic Details
Main Author: Uroš Mlakar
Format: Article
Language:English
Published: Slovenian Medical Association 2004-12-01
Series:Zdravniški Vestnik
Subjects:
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/2425